ALTERITY THERAPEUTICS LIMITED - Announcements

0.00%

1.4¢

Market Cap $128.9M

Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

ATH	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/10	65.46KB	Share
ATH	Appendix 3X		14/01/10	43.5KB	Share
ATH	Appointment of Independent Director		14/01/10	49.02KB	Share
ATH	Change in substantial holding		07/01/10	500.67KB	Share
ATH	Change in substantial holding		01/12/09	27.49KB	Share
ATH	Appendix 3B and Section 708A Notice		27/11/09	159.72KB	Share
ATH	Results of 2009 Annual General Meeting		27/11/09	28.36KB	Share
ATH	Prana to Present at Windhover's Therapeutic Area Conference		12/11/09	27.49KB	Share
ATH	Change in substantial holding		10/11/09	206.19KB	Share
ATH	Becoming a substantial holder		06/11/09	71.63KB	Share
ATH	Becoming a substantial holder		06/11/09	61.44KB	Share
ATH	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/09	122.41KB	Share
ATH	Notice of Annual General Meeting/Proxy Form		23/10/09	296.4KB	Share
ATH	Change in substantial holding		09/10/09	165.44KB	Share
ATH	Appendix 3B and Section 708A Notice		08/10/09	125.99KB	Share
ATH	Change in substantial holding		06/10/09	189.92KB	Share
ATH	Form F-3		28/09/09	181.52KB	Share
ATH	Form 20-F		25/09/09	1.18MB	Share
ATH	Change in substantial holding		24/09/09	218.32KB	Share
ATH	Annual Report 2009		23/09/09	1.72MB	Share
ATH	Becoming a substantial holder		18/09/09	24.95KB	Share
ATH	Change in substantial holding		16/09/09	140.94KB	Share
ATH	Becoming a substantial holder		15/09/09	727.57KB	Share
ATH	Appendix 3B and Section 708A Notice		11/09/09	251.48KB	Share
ATH	Prana Secures $6 million Additional Financing	PRICE SENSITIVE	09/09/09	34.01KB	Share
ATH	Appendix 3B and Section 708(A) Notice		02/09/09	253.91KB	Share
ATH	Prana to Present at Rodman and Renshaw Global Conference		02/09/09	30.87KB	Share
ATH	Preliminary Final Report	PRICE SENSITIVE	26/08/09	223.36KB	Share
ATH	Prana Allowed Key Patent for PBT2 in the United States	PRICE SENSITIVE	12/08/09	40.4KB	Share
ATH	Post Effective Amendment to Form F-3 registration statement		06/08/09	30.81KB	Share
ATH	Prana is Granted Key Patent by European Patent Office	PRICE SENSITIVE	05/08/09	31.67KB	Share
ATH	Change of Director's Interest Notices		04/08/09	97.62KB	Share
ATH	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/09	71.11KB	Share
ATH	Prana's Head of Research Presents New Efficacy Data		16/07/09	38.51KB	Share
ATH	Appendix 3B and Section 708A Notice		15/07/09	180.92KB	Share
ATH	Prana to Provide Update on PBT2 Efficacy Data		10/07/09	33.97KB	Share
ATH	Appendix 3B and Section 708A Notice		16/06/09	136.56KB	Share
ATH	Appendix 4C - Quarterly Report	PRICE SENSITIVE	30/04/09	78.88KB	Share
ATH	Study Corroborates Prana's AD Strategy	PRICE SENSITIVE	02/04/09	101.72KB	Share
ATH	Prana's PBT2 Prevents Synaptic Loss in Alzheimer's Disease	PRICE SENSITIVE	11/03/09	30.14KB	Share
ABB +GDG ADY CQE AJL AMU ANG APD ARR (ASX) 20200701 ARU ATR AVM AVX AWC AXQ BBI BBP BDG BEC BNB BTR BUL BVA CBH CCL CCP CDA CEG CER CFU CGG PRG CIL CIX CIY AEL COZ CPR CQT CRE CSS CTY CUE CUV CVN CWT CXG CXS DOM DTL DUE GSL EFG EPX ESG ETC EXT RHK FPG FRI FWD GJT GMI GOW GPG GZL HDI NGI HIN HLG HRR HST IBA IDT IEF IFM IGR IIF OBL ACN JBH KBC KMN LLA LNG LRF LWB LYL MAF AEV MDT MEO MGX MIX GG8 MPF MRM MRU MSB MSL MUE NCK NFK BLV NOD KZA OEL SYN OGC ORL OZL PBB PBD ATH PEM PME PPI PPP PRC PRU PSA PVE QTM RAT RCT REU RFG RHI RIV RJT RMS RNY RRT RUL SAV SFH SGH SGT SHL SKI SLV SMM SNO SOT SRK SST SUL TGP TIM TOX TPX TSO TTY TWR VGH VIR VMG WEB	SandP Announces March SP/ASX Index Rebalance		06/03/09	38.96KB	Share
ATH	Form 6-K		23/02/09	107.03KB	Share
ATH	Appendix 4D	PRICE SENSITIVE	18/02/09	864.42KB	Share
ATH	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	79.26KB	Share
ATH	Co-founding Scientist to Present at Healthcare Conference		05/01/09	32.21KB	Share
ATH	Appendix 3B and Section 708A Notice		03/12/08	140.45KB	Share
ATH	Results of Annual General Meeting		28/11/08	60.23KB	Share
ATH	Prana Provides Update on Research and Development Programs	PRICE SENSITIVE	28/11/08	31.96KB	Share

ATHAppendix 4C - quarterly
29/01/10	PRICE SENSITIVE	65.46KB	Share
ATHAppendix 3X
14/01/10		43.5KB	Share
ATHAppointment of Independent Director
14/01/10		49.02KB	Share
ATHChange in substantial holding
07/01/10		500.67KB	Share
ATHChange in substantial holding
01/12/09		27.49KB	Share
ATHAppendix 3B and Section 708A Notice
27/11/09		159.72KB	Share
ATHResults of 2009 Annual General Meeting
27/11/09		28.36KB	Share
ATHPrana to Present at Windhover's Therapeutic Area Conference
12/11/09		27.49KB	Share
ATHChange in substantial holding
10/11/09		206.19KB	Share
ATHBecoming a substantial holder
06/11/09		71.63KB	Share
ATHBecoming a substantial holder
06/11/09		61.44KB	Share
ATHAppendix 4C - quarterly
28/10/09	PRICE SENSITIVE	122.41KB	Share
ATHNotice of Annual General Meeting/Proxy Form
23/10/09		296.4KB	Share
ATHChange in substantial holding
09/10/09		165.44KB	Share
ATHAppendix 3B and Section 708A Notice
08/10/09		125.99KB	Share
ATHChange in substantial holding
06/10/09		189.92KB	Share
ATHForm F-3
28/09/09		181.52KB	Share
ATHForm 20-F
25/09/09		1.18MB	Share
ATHChange in substantial holding
24/09/09		218.32KB	Share
ATHAnnual Report 2009
23/09/09		1.72MB	Share
ATHBecoming a substantial holder
18/09/09		24.95KB	Share
ATHChange in substantial holding
16/09/09		140.94KB	Share
ATHBecoming a substantial holder
15/09/09		727.57KB	Share
ATHAppendix 3B and Section 708A Notice
11/09/09		251.48KB	Share
ATHPrana Secures $6 million Additional Financing
09/09/09	PRICE SENSITIVE	34.01KB	Share
ATHAppendix 3B and Section 708(A) Notice
02/09/09		253.91KB	Share
ATHPrana to Present at Rodman and Renshaw Global Conference
02/09/09		30.87KB	Share
ATHPreliminary Final Report
26/08/09	PRICE SENSITIVE	223.36KB	Share
ATHPrana Allowed Key Patent for PBT2 in the United States
12/08/09	PRICE SENSITIVE	40.4KB	Share
ATHPost Effective Amendment to Form F-3 registration statement
06/08/09		30.81KB	Share
ATHPrana is Granted Key Patent by European Patent Office
05/08/09	PRICE SENSITIVE	31.67KB	Share
ATHChange of Director's Interest Notices
04/08/09		97.62KB	Share
ATHAppendix 4C - quarterly
30/07/09	PRICE SENSITIVE	71.11KB	Share
ATHPrana's Head of Research Presents New Efficacy Data
16/07/09		38.51KB	Share
ATHAppendix 3B and Section 708A Notice
15/07/09		180.92KB	Share
ATHPrana to Provide Update on PBT2 Efficacy Data
10/07/09		33.97KB	Share
ATHAppendix 3B and Section 708A Notice
16/06/09		136.56KB	Share
ATHAppendix 4C - Quarterly Report
30/04/09	PRICE SENSITIVE	78.88KB	Share
ATHStudy Corroborates Prana's AD Strategy
02/04/09	PRICE SENSITIVE	101.72KB	Share
ATHPrana's PBT2 Prevents Synaptic Loss in Alzheimer's Disease
11/03/09	PRICE SENSITIVE	30.14KB	Share
ABB +GDG ADY CQE AJL AMU ANG APD ARR (ASX) 20200701 ARU ATR AVM AVX AWC AXQ BBI BBP BDG BEC BNB BTR BUL BVA CBH CCL CCP CDA CEG CER CFU CGG PRG CIL CIX CIY AEL COZ CPR CQT CRE CSS CTY CUE CUV CVN CWT CXG CXS DOM DTL DUE GSL EFG EPX ESG ETC EXT RHK FPG FRI FWD GJT GMI GOW GPG GZL HDI NGI HIN HLG HRR HST IBA IDT IEF IFM IGR IIF OBL ACN JBH KBC KMN LLA LNG LRF LWB LYL MAF AEV MDT MEO MGX MIX GG8 MPF MRM MRU MSB MSL MUE NCK NFK BLV NOD KZA OEL SYN OGC ORL OZL PBB PBD ATH PEM PME PPI PPP PRC PRU PSA PVE QTM RAT RCT REU RFG RHI RIV RJT RMS RNY RRT RUL SAV SFH SGH SGT SHL SKI SLV SMM SNO SOT SRK SST SUL TGP TIM TOX TPX TSO TTY TWR VGH VIR VMG WEBSandP Announces March SP/ASX Index Rebalance
06/03/09		38.96KB	Share
ATHForm 6-K
23/02/09		107.03KB	Share
ATHAppendix 4D
18/02/09	PRICE SENSITIVE	864.42KB	Share
ATHAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	79.26KB	Share
ATHCo-founding Scientist to Present at Healthcare Conference
05/01/09		32.21KB	Share
ATHAppendix 3B and Section 708A Notice
03/12/08		140.45KB	Share
ATHResults of Annual General Meeting
28/11/08		60.23KB	Share
ATHPrana Provides Update on Research and Development Programs
28/11/08	PRICE SENSITIVE	31.96KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.4¢		Change 0.000(0.00%)		Mkt cap ! $128.9M

Open	High	Low	Value	Volume
1.3¢	1.4¢	1.3¢	$49.17K	3.596M

Buyers (Bids)

No.	Vol.	Price($)
41	22025579	1.3¢

Sellers (Offers)

Price($)	Vol.	No.
1.4¢	2141193	6

View Market Depth

No.	Vol.	Price($)
41	22025579	0.013
37	17398569	0.012
16	8615237	0.011
33	15213355	0.010
13	6001877	0.009

Price($)	Vol.	No.
0.014	2141193	6
0.015	18539645	10
0.016	4123104	13
0.017	7408424	11
0.018	11761167	21

Last trade - 16.10pm 12/08/2025 (20 minute delay)


Last 1.3¢		Change 0.000 ( 7.14 %)
Open	High	Low	Volume
1.4¢	1.4¢	1.3¢	3211381
Last updated 15.59pm 12/08/2025 ?

ATH (ASX) Chart

ALTERITY THERAPEUTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available